-
Oppenheimer Has $18.50 Target On WuXi PharmaTech (WX)
Tuesday, September 21, 2010 - 8:10am | 131Oppenheimer & Co. has an Outperform rating on WuXi PharmaTech (Cayman) Inc. (NYSE: WX), with a $18.50 price target, as it hosted WX at an NDR. In the research note, Oppenheimer writes, "Key takeaways include: 1) China's CRO industry will continue to grow at double-digits, driven by the rising...
-
CTIC Stays Neutral - Analyst Blog
Monday, September 20, 2010 - 4:00pm | 585We are maintaining our Neutral recommendation on Cell Therapeutics Inc. (CTIC) with a target price of $0.25. Cell Therapeutics, based in Seattle, Washington, is focused on developing drugs for cancer. The company's lead pipeline candidate, pixantrone (proposed trade name: Pixuvri), is being...
-
Goldman Sachs Color On CROs
Monday, September 20, 2010 - 10:15am | 200Goldman Sachs reports on Parexel International Corporation (NASDAQ: PXRL) and Pharmaceutical Product Development, Inc. (NASDAQ: PPDI), stating that GlaxoSmithKline (NYSE: GSK) is negotiating contracts to enter into strategic relationships with these late-stage CROs: For Parexel, Goldman states: "We...
-
Zacks #5 Rank Additions for Friday - Tale of the Tape
Friday, September 17, 2010 - 8:36am | 338Here are 5 stocks added to the Zacks #5 Rank ("strong sell") List today: Acorn Intl Inc (ATV) Alere Inc (ALR) Burger King Holdings Inc (BKC) Covance Inc (CVD) Culp Inc (CFI) View the entire Zacks #5 Rank List. ALERE INC (ALR): Free Stock Analysis Report ACORN INTL-ADR (ATV): Free Stock...
-
Waters and Hitachi High Technologies America Enter into Distribution Agreement
Thursday, September 16, 2010 - 8:32am | 133Waters Corporation (NYSE: WAT) and Hitachi High Technologies America, Inc. have entered into an agreement granting HTA the ability to sell Waters® sample preparation and liquid chromatography columns to Hitachi users in North America effective immediately. "This agreement with HTA will expand...
-
PAO ACUCAR-GDR (CBD) - Profit Tracks
Tuesday, September 14, 2010 - 7:11pm | 585Since inception in 1988, the S&P 500 has outperformed the Zacks #5 Rank List - Stocks to Sell Now by 80% annually (+2% versus +10%). While the rest of Wall Street continued to tout stocks during the market declines of the last few years, Zacks told investors which stocks to sell or avoid....
-
Zacks Sell List Highlights: Amazon.com, Companhia Brasileira de Distrib, Techne and Landauer - Press Releases
Tuesday, September 14, 2010 - 7:10pm | 1294For Immediate Release Chicago, IL –September 14, 2010 – Zacks.com releases details on a group of stocks that are currently members of the exclusive Zacks #5 Rank List – Stocks to Sell Now. These stocks are currently rated as a Zacks Rank #5 (Strong Sell): Amazon.com, Inc. (AMZN) and Companhia...
-
Forest Labs Responds to CRL - Analyst Blog
Tuesday, September 14, 2010 - 5:06pm | 575Forest Laboratories Inc. (FRX) recently announced that it has submitted a response to the complete response letter (CRL) issued by the US Food and Drug Administration (FDA) in mid-May for Daxas (roflumilast). Forest Labs and partner, Nycomed GmbH, are looking to get Daxas approved for the treatment...
-
CTIC to Challenge FDA Decision - Analyst Blog
Tuesday, September 14, 2010 - 4:33pm | 498Recently, Cell Therapeutics Inc. (CTIC) announced that it will appeal against the decision of the US Food and Drug Administration (FDA) to deny approval to the company’s lead candidate, pixantrone. The candidate is being developed for the treatment of relapsed or refractory aggressive non-Hodgkin...
-
Top 4 NYSE Mid-Cap Stocks In The Technology Sector With The Highest ROE (AMD, CEL, NSM, WAT)
Tuesday, September 14, 2010 - 6:06am | 128Below are the top mid-cap technology stocks on the NYSE in terms of return on equity. The trailing-twelve-month return on equity at Advanced Micro Devices Inc (NYSE: AMD) is 913.59%. AMD's quarterly revenue gained 39.60% y/y. The trailing-twelve-month return on equity at Cellcom Israel Ltd (NYSE:...
-
Earnings Scheduled For September 14 (KR, BBY, PLL, CHP, KOOLD, WNI, CBRL, COOL, MDZ)
Tuesday, September 14, 2010 - 5:58am | 242Kroger (NYSE: KR) is likely to earn $0.36 per share on revenue of $18.73 billion in the second quarter. Best Buy Co Inc (NYSE: BBY) is expected to post its Q2 EPS of $0.44 on $11.65 billion in revenue. Pall Corp (NYSE: PLL) may post its FQ4 profit of $0.64 per share on revenue of $671.02 million. C...
-
Bruker Corp. Benefitial Owner Sells 539,750 Shares of BRKR
Monday, September 13, 2010 - 4:37pm | 56In a Form 4 filed after the bell today, Bruker Corp. (NASDAQ: BRKR) Director and Beneficial Owner, Dirk D. Laukien, reported that he sold 539,750 shares of BRKR on September 10th for an average price of $13.27. The transaction totaled $7,162,483. Mr. Laukien owns 17,726,397 direct shares of BRKR....
-
Bruker Corp. Director Sells 539,750 Shares of BRKR
Monday, September 13, 2010 - 4:35pm | 55In a Form 4 filed after the bell today, Bruker Corp. (NASDAQ: BRKR) Director and Beneficial Owner, Joerg Laukien, reported that he sold 539,750 shares of BRKR on September 10th for an average price of $13.27. The transaction totaled $7,162,483. Mr. Laukien owns 19,951,180 direct shares of BRKR....
-
MannKind Evenly Poised - Analyst Blog
Friday, September 10, 2010 - 5:06pm | 515We are maintaining our Neutral recommendation on MannKind Corporation (MNKD) with a target price of $6.25. MannKind is a Valencia, California-based biopharmaceutical company focused on the discovery, development and commercialization of therapeutic products for diabetes, cancer and inflammatory...
-
ERT Announces Upcoming Retirement of CEO
Friday, September 10, 2010 - 4:02pm | 72eResearchTechnology, Inc. (ERT), (Nasdaq: ERES) today announced that Michael McKelvey will be retiring from his positions as President and Chief Executive Officer and a director of ERT. The Company's Board of Directors has begun a search for a successor. Dr. McKelvey will continue in his current...